Appendix B: Panel Roster and Financial Disclosures

Hepatitis C Virus

Hepatitis C Virus 
Member Financial Disclosure
Company Relationship
Bansal, Meena Mount Sinai Hospital None N/A
Kim, Arthur Harvard Medical School BioMarin, Inc. Advisory Board
UpToDate Royalties
Kim, Nina University of Washington None N/A
Naggie, Susanna Duke University Abbvie Research Support
BioMarin, Inc Advisory Board
FHI 360 Event Adjudication Committee
Gilead Sciences Research Support
PRA Health Sciences/Bristol-Myers Squibb Event Adjudication Committee
Vir Biotechnology Scientific Advisor (stock option)
Sulkowski, Mark* Johns Hopkins University AbbVie Advisory Board, Research Support
Gilead Sciences Advisory Board, Data Safety Monitoring Board, Research Support
Villanueva, Merceditas Yale University School of Medicine None N/A
Wyles, David Denver Health Medical Center and University of Colorado School of Medicine Gilead Sciences Research Support
* Group lead

Note: Members were asked to disclose all relationships from 12 months prior to the reviewed date. The period of reporting was from August 1, 2018, through August 1, 2019


Aug. 01, 2019

Download Guidelines